Livermore

Mass General Brigham, Inc

SEC CIK
0001678378

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 7, 2026.SEC

Positions
6
0 vs. Q1 2026
Total value
$361.08M
−$107.84M (−23.0%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

Mass General Brigham, Inc holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
ISHARES TR464288257MSCI ACWI ETF1,259,657$197.73M54.76%−893,820−41.5%Reduced–
KRMNKARMAN HLDGS INCCOMMON STOCK1,562,054$77.98M21.60%00.0%UnchangedView
RVMDREVOLUTION MEDICINES INCCOM344,091$64.44M17.85%00.0%UnchangedView
TNGXTANGO THERAPEUTICS INCCOM354,192$11.07M3.07%00.0%UnchangedView
MAZEMAZE THERAPEUTICS INCCOM239,994$7.16M1.98%00.0%UnchangedView
MDLNMEDLINE INCCOM CL A68,413$2.7M0.75%−1,944−2.8%ReducedView

13F filings by quarter

Mass General Brigham, Inc 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 7, 20266$361.08Mvs. Q1 2026SEC
Q1 2026May 5, 20266$468.92Mvs. Q4 2025SEC
Q4 2025Jan 27, 20267$809.79M–SEC
Q3 2024Oct 16, 20245$43.63Mvs. Q2 2024SEC
Q2 2024Jul 31, 20244$20.54Mvs. Q1 2024SEC
Q1 2024Apr 4, 20245$57.13Mvs. Q4 2023SEC
Q4 2023Jan 24, 20242$28.02Mvs. Q3 2023SEC
Q3 2023Oct 23, 20232$10.78Mvs. Q2 2023SEC
Q2 2023Jul 21, 20237$109.93Mvs. Q1 2023SEC
Q1 2023Apr 5, 20236$128.31Mvs. Q4 2022SEC
Q4 2022Jan 19, 20235$140.45Mvs. Q3 2022SEC
Q3 2022Oct 19, 20223$192.31Mvs. Q2 2022SEC
Q2 2022Jul 27, 20223$213.82Mvs. Q1 2022SEC
Q1 2022Apr 15, 20225$235.14Mvs. Q4 2021SEC
Q4 2021Jan 19, 20227$282.04Mvs. Q3 2021SEC
Q3 2021Oct 8, 20217$370.62Mvs. Q2 2021SEC
Q2 2021Jul 19, 20219$409.9Mvs. Q1 2021SEC
Q1 2021Apr 12, 20213$639.42M–SEC